- Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
-
Li X, Huang H, Xu B, Guo H, Lin Y, Ye S, Yi J, Li W, Wu X, Wang W, Zhan H, Xie D, Peng J, Cao Y, Pu X, Guo C, Hong H, Wang Z, Fang X, Zhou Y, Lin S, Liu Q, Lin T
- KMID: 2454284
- Cancer Res Treat.
- 2019 Jul;51(3):919-932.
- doi: 10.4143/crt.2018.230
PURPOSE: Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone administered every 3 weeks (R-CHOP-21) is the standard care for diffuse large B-cell lymphoma (DLBCL). It is unknown whether the dose-dense R-CHOP... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent
-
Sekiguchi , Hamano A, Kitagawa T, Kurihara Y, Ito K, Kurimoto M, Watanabe K, Hirano K, Noto S, Yamada K, Takezako N
- KMID: 2451029
- Blood Res.
- 2018 Jun;53(2):117-122.
- doi: 10.5045/br.2018.53.2.117
BACKGROUND: Waldenström Macroglobulinemia (WM) is a rare subtype of indolent B-cell lymphoma, and prospective randomized studies on WM are scarce. The R-CHOP therapy [rituximab (R), cyclophosphamide, hydroxy-doxorubicin, vincristine, and prednisone]... -
- CITED
-
- Close
- SHARE
-
- Close
- Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
-
Shin J, Lee JO, Choe JY, Bang SM, Lee JS
- KMID: 2367525
- Cancer Res Treat.
- 2017 Jan;49(1):274-278.
- doi: 10.4143/crt.2016.076
Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin’s lymphoma arising from a B-cell lineage characterized by the formation of malignant effusion in body cavities without evidence of a... -
- CITED
-
- Close
- SHARE
-
- Close
- Utility Analysis for Pegfilgrastim in DLBCL Patients on R-CHOP Regimen
-
Jung HW, Kim JM, Min MS, Lee YM, Bang JS
- KMID: 2226406
- Korean J Clin Pharm.
- 2015 Sep;25(3):151-158.
- doi: 10.0000/kjcp.2015.25.3.151
OBJECTIVE: This study was designed to compare pegfilgrastim and filgrastim in diffuse large B-cell lymphoma (DLBCL) patients treated with a rituximab with cyclophosphamide, hydroxydaunorubicin, oncovin, and prednisone (R-CHOP) regimen in... -
- CITED
-
- Close
- SHARE
-
- Close
- Prophylactic Effect of Pegfilgrastim on Febrile Neutropenia in Patients with Non-Hodgikin's Lymphoma
-
Jo J, Bang JS
- KMID: 2068831
- Korean J Clin Pharm.
- 2015 Jun;25(2):80-93.
- doi: 10.0000/kjcp.2015.25.2.80
OBJECTIVE: Pegfilgrastim is recently introduced that is long acting G-CSF for prophylaxis of febrile neutropenia. Treatment of non-Hodgikin's lymphoma (NHL) with R-CHOP is classified with relative high risk of febrile... -
- CITED
-
- Close
- SHARE
-
- Close
- Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth
-
Lee EJ, Ahn KH, Hong SC, Lee EH, Park Y, Kim BS
- KMID: 2314021
- Obstet Gynecol Sci.
- 2014 Nov;57(6):526-529.
- doi: 10.5468/ogs.2014.57.6.526
Lymphoma, especially non-Hodgkin's lymphoma is extremely rare in pregnancy. A 24-year-old pregnant woman was diagnosed with diffuse large B-cell lymphoma (DLBCL), a subgroup of non-Hodgkin's lymphoma, at 24 weeks' gestation,... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
-
Choi YW, Jeong SH, Ahn MS, Lee HW, Kang SY, Choi JH, Jin UR, Park JS
- KMID: 2069930
- J Korean Med Sci.
- 2014 Nov;29(11):1493-1500.
- doi: 10.3346/jkms.2014.29.11.1493
Febrile neutropenia (FN) is the major toxicity of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen in the treatment of diffuse large B-cell lymphoma (DLBCL). The prediction of neutropenia... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Primary Adrenal Diffuse Large B-cell Lymphoma Achieving Complete Remission with Rituximab-CHOP Chemotherapy
-
Kim KM, Yoon DH, Lee SG, Lim SN, Sug LJ, Huh J, Suh C
- KMID: 1779176
- J Korean Med Sci.
- 2009 Jun;24(3):525-528.
- doi: 10.3346/jkms.2009.24.3.525
Primary adrenal lymphoma is a very rare extranodal lymphoma; its clinical features consist of a high incidence of bilateral adrenal involvement and diffuse large B-cell lymphoma. We report a patient... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case Report of Posttransplant Lymphoproliferative Disorders Successfully Treated with R-CHOP in Korea
-
Yoon SH, Kim SJ, Lee HW, Hwang DY, Kim JS, Cheong JW, Min YH
- KMID: 2252203
- Korean J Hematol.
- 2008 Jun;43(2):106-112.
- doi: 10.5045/kjh.2008.43.2.106
Posttransplant lymphoproliferative disorder (PTLD) is a group of heterogeneous lymphoid diseases that cause serious complications after organ or stem cell transplantation. The onset of PTLD is mostly due to EBV... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Primary Tracheal Lymphoma of a 65-year-old Female: Extremely Rare Primary Localization of a Diffuse Large B-cell Lymphoma
-
Ko YS, Lim YJ, Yang JH, So CS, Kim MJ, Park SH, Park S, Huh MN, Kim JH, Kim CH, Shim JW, Hwang HS, Park YI, Jung JY
- KMID: 2252234
- Korean J Hematol.
- 2007 Dec;42(4):439-444.
- doi: 10.5045/kjh.2007.42.4.439
Primary extranodal non-Hodgkin's lymphomas comprise approximately 10% of all non-Hodgkin's lymphomas. However, primary tracheal non-Hodgkin's lymphoma is extremely rare, being mainly mucosa-associated lymphoid tissue lymphoma. A 65-year-old female has dry... -
- CITED
-
- Close
- SHARE
-
- Close
